Exhibit 10.31
SUBSCRIPTION AGREEMENT
Subscription
Agreement (together with the schedules and exhibits hereto, this
“ Agreement ”), dated as of _________, 2008, by
and between BioDrain Medical, Inc., a Minnesota corporation
(“the Company ”), and each of the Persons (as
defined below) who has executed a signature page to this Agreement
(each a “ Purchaser ,” and together, the “
Purchasers ”).
W I T N E S S E T H:
WHEREAS, the Company desires to issue and sell to the
Purchasers, and the Purchasers desire to purchase from the Company,
a minimum of $0.8 million and a maximum of $1.7 million of Units
(as such term is defined below) as set forth below.
NOW,
THEREFORE, in
consideration of the premises and the mutual covenants and
agreements hereinafter contained, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby
acknowledged, intending to be legally bound, the parties hereto
hereby agree as follows:
1. Offer and Sale of
Securities.
1.1
The Offering . The Company is offering for sale of a minimum
of 2,285,715 and a maximum of 4,857,144 units of Company
securities. Each “unit” shall consist of one share of
Company common stock, par value $0.001 per share (“
Share ”), and a warrant to purchase one share of
Company common stock at $0.46 per share (“ Warrant
”). The Shares, Warrants, and Units offered hereby, and the
underlying shares of Common Stock, are sometimes referred to herein
as the “ Securities ”. The Purchasers of the
Units shall have the benefit of certain registration rights in
respect of the Shares (including Shares underlying the Warrants or
“Warrant Shares”) on the terms and conditions of a
Registration Rights Agreement, in the form of Exhibit B
hereto (the “ Registration Rights Agreement ”).
The Company is offering Units (the “ Offering ”)
for sale only to individuals, entities or groups, including,
without limitation, corporations, limited liability companies,
limited or general partnerships, joint ventures, associations,
joint stock companies, trusts, unincorporated organizations, or
governments or any agencies or political subdivisions thereof
(each, a “ Person ”) who are “accredited
investors” (as defined herein). All subscription proceeds
will be paid upon subscription to the account or accounts of
Richardson & Patel LLP, the escrow agent utilized by the
Company for receipt of funds (the “ Escrow Agent
”).
1.2
Subscription . Subject to the terms and conditions
hereinafter set forth in this Agreement, each Purchaser hereby
offers to purchase, at a price of $0.35 per share, the number of
Units set forth beneath each such Purchaser’s name on the
signature pages of this Agreement, for an aggregate purchase price
(the “Purchase Price”) to be paid by such Purchaser in
the amount set forth on the signature page beneath such
Purchaser’s name, to such account or accounts as the Company
may specify by written notice to the Purchaser.
1.3
Subscription Procedures . To submit this Subscription, each
Purchaser must deliver (i) this Agreement, including, without
limitation, the annexed Purchaser Questionnaire, both duly
completed and executed and (ii) an executed Registration Rights
Agreement to the following address unless otherwise advised by the
Company:
- 1 -
|
|
|
|
|
BioDrain Medical, Inc.
699 Minnetonka Highlands Lane
Orono, Minnesota 55356-9728
Attention: Kevin Davidson
|
Each
Purchaser shall, promptly following the delivery of the
subscription documents as described above, deliver and pay the
applicable purchase price in full for the Units being subscribed
for by such Purchaser, in the amount of $0.35 for each Unit, in
U.S. dollars, in immediately available funds, in accordance with
the payment instructions attached hereto as Exhibit C . The
Company may accept or reject subscriptions, in whole or in part in
its sole discretion. The Company shall notify each Purchaser of the
portion, if any, of such Purchaser’s subscription which has
been accepted and, if any portion of a Purchaser’s
subscription is rejected, shall cause the Escrow Agent to refund to
such Purchaser the purchase price paid by the Purchaser for the
shares of Units with respect to which such Purchaser’s
subscription was rejected.
2. Closing
.
Upon
acceptance of subscriptions for Units from a Purchaser, the Company
may hold a closing of the purchase and sale of such Securities at
any time after receipt of an aggregate amount of $800,000 of Units
has been sold by the Company (the “ Initial Closing
”). The Company may thereafter hold one or more additional
closings (each closing, including the Initial Closing, a “
Closing, ” and the final closing, the “ Final
Closing ”) upon the purchase and sale of additional
Securities until an aggregate amount of up to $1,700,000 (the
“ Maximum Offering ”) of Units has been sold by
the Company. The date of the Initial Closing will be referred to as
the “Initial Closing Date” and the date of the Final
Closing is referred to as the “Final Closing Date.” At
the Closing with respect to the subscription by each Purchaser, to
the extent the same is accepted by the Company, the Company will
register in the name of each such Purchaser that number of
Securities being purchased by such Purchaser in accordance with the
information on the applicable signature page of this
Agreement.
2.1
Escrow . Pending each Closing, all funds paid in respect of
this Agreement with regard to such Closing shall be deposited in an
escrow account (the “ Escrow Account ”)
maintained by the Escrow Agent pursuant to an Escrow Agreement
among the Company, Purchaser and Escrow Agent, set forth as
Exhibit D . The Escrow Account shall not be interest
bearing. If the Company accepts subscriptions for the Securities at
or prior to the Initial Closing Date or the Final Closing Date, as
the case may be, then all subscription proceeds received for
subscriptions accepted by the Company prior to such Closing Date
shall be paid over to the Company at each Closing, net of any
offering expenses, which shall be paid to the appropriate parties
at each such Closing. If the Company shall not have received and
accepted a Purchaser’s subscription or if the Offering is
terminated and no Closing occurs, then that subscription shall be
void and all funds paid hereunder by such Purchaser, without
deduction therefrom or interest thereon, shall be promptly returned
to such Purchaser. If the Offering is terminated and no Closing
occurs, then all subscriptions shall be void and all funds paid
hereunder by Purchasers, without deduction therefrom or interest
thereon, shall be promptly returned to the Purchasers. The Offering
shall automatically terminate, all subscriptions shall be void and
all funds shall be refunded to the Purchasers as provided in this
Section 2.1 (which refunds shall be made on or before March 31,
2008), unless on or before March 31, 2008 all of the conditions set
forth in Section 3 hereof have been satisfied and the Initial
Closing shall have occurred.
2.2.
Return of Funds . Each Purchaser hereby authorizes and
directs the Escrow Agent to return or direct the return of any
funds from the Escrow Account, without deduction therefrom or
interest thereon, to the same account from which the funds were
originally drawn, to the extent that such Purchaser’s
subscription is not accepted prior to the termination of the
Offering.
- 2 -
3. Conditions to the
Obligations of each Purchaser at Closing .
The
obligation of each Purchaser to purchase the Securities subscribed
for by such Purchaser at the Closing is subject to the satisfaction
on or prior to the Closing Date of the following conditions, each
of which may be waived by the applicable Purchaser:
3.1
Representations and Warranties . The representations and
warranties of the Company contained in this Agreement which are
qualified as to materiality must be true and correct in all
respects and the representations and warranties of the Company
contained in this Agreement which are not qualified as to
materiality must be true and correct in all material respects as of
the Closing Date except to the extent that the representations and
warranties relate to an earlier date in which case the
representations and warranties must be true and correct as written
or true and correct in all material respects, as the case may be,
as of the earlier date.
3.2
Performance of Covenants . The Company shall have performed
or complied in all material respects with all covenants and
agreements required to be performed by it on or prior to the
Closing pursuant to this Agreement.
3.3
No Injunctions; etc . No court or governmental injunction,
order or decree prohibiting the purchase and sale of the Units will
be in effect. There will not be in effect any law, rule or
regulation prohibiting or restricting the sale or requiring any
consent or approval of any Person that has not been obtained to
issue and sell the Units to the Purchasers.
3.4
Closing Documents . At each Closing, the Company shall have
delivered to the Escrow Agent the following:
|
|
|
|
|
|
(a) a certificate evidencing the
Units purchased by such Purchaser;
|
|
|
|
|
|
|
(b) an Escrow Agreement duly
executed by the Company; and
|
|
|
|
|
|
|
(c) a Registration Rights
Agreement duly executed by the Company.
|
3.5
Waivers and Consents . The Company will have obtained all
consents and waivers necessary to (i) execute and deliver this
Agreement and all related documents and agreements, and (ii) to
issue and deliver the Units, and all such consents and waivers will
be in full force and effect.
4. Conditions to the
Obligations of the Company at Closing .
The
obligation of the Company to issue and sell the Units to any
Purchaser is subject to the satisfaction on or prior to each
Closing Date of the following conditions, each of which may be
waived by the Company:
4.1
Receipt of Purchase Price . The Escrow Agent shall have
received payment in full in immediately available funds in U.S.
dollars of the Purchase Price for the Units with respect to which
the Company has accepted the Subscription made by such Purchaser by
means of this Agreement.
4.2
Representations and Warranties . The representations and
warranties of the Purchaser contained in this Agreement which are
qualified as to materiality must be true and correct in all
respects and the representations and warranties of the Purchaser
contained in this Agreement which are not qualified as to
materiality must be true and correct in all material respects as of
the applicable Closing Date.
- 3 -
4.3
Performance of Covenants . The Purchaser will have performed
or complied in all material respects with all covenants and
agreements required to be performed by the Purchasers on or prior
to the Closing pursuant to this Agreement.
4.4
Purchaser Questionnaire . All of the information furnished
by such Purchaser in the confidential purchaser questionnaire
accompanying this Agreement (the “ Purchaser
Questionnaire ”) shall have been accurate and complete in
all material respects.
4.5
No Injunctions . No court or governmental injunction, order
or decree prohibiting the purchase or sale of the Units will be in
effect.
4.6
Closing Document . The Purchasers will have delivered to the
Company the Registration Rights Agreement duly executed by the
Purchasers.
5. Representations and
Warranties of each Purchaser .
Each
Purchaser, in order to induce the Company to perform this
Agreement, hereby represents and warrants, severally and not
jointly, as follows:
5.1
Due Authorization . Each Purchaser represents for such
Purchaser to the Company that such Purchaser has full power and
authority and has taken all action necessary to authorize such
Purchaser to execute, deliver and perform such Purchaser’s
obligations under this Agreement. This Agreement is the legal,
valid and binding obligation of such Purchaser in accordance with
its terms.
5.2
Accredited Investor . Each Purchaser represents that such
Purchaser is an Accredited Investor as that term is defined in
Regulation D promulgated under the Securities Act of 1933, as
amended (the “ Securities Act ”).
5.3
No Investment Advice . The Company has not made any other
representations or warranties to such Purchaser other than as set
forth herein or incorporated herein by reference with respect to
the Company or rendered any investment advice.
5.4
Investment Experience . Each Purchaser represents that such
Purchaser has not authorized any Person to act as a Purchaser
Representative (as that term is defined in Regulation D of the
General Rules and Regulations under the Securities Act) in
connection with this transaction. Such Purchaser has such knowledge
and experience in financial, investment and business matters that
such Purchaser is capable of evaluating the merits and risks of the
prospective investment in the securities of the Company. Such
Purchaser has consulted with such independent legal counsel or
other advisers as such Purchaser has deemed appropriate to assist
such Purchaser in evaluating the proposed investment in the
Company.
5.5
Adequate Means . Each Purchaser represents as to such
Purchaser that such Purchaser (i) has adequate means of providing
for such Purchaser’s current financial needs and possible
contingencies; and (ii) can afford (a) to hold unregistered
securities for an indefinite period of time as required; and (b)
sustain a complete loss of the entire amount of the
subscription.
5.6
Access to Information . Each Purchaser represents that such
Purchaser has been afforded the opportunity to ask questions of,
and receive answers from the officers and/or directors of the
Company acting on its behalf concerning the terms and conditions of
this transaction and to obtain any additional information, to the
extent that the Company possesses such information or can acquire
it without unreasonable effort or expense, necessary to verify the
accuracy of the information furnished; and
- 4 -
has had such opportunity to the
extent such Purchaser considers it appropriate in order to permit
such Purchaser to evaluate the merits and risks of an investment in
the Company. It is understood that all documents, records and books
pertaining to this investment have been made available for
inspection, and that the books and records of the Company will be
available upon reasonable notice for inspection by investors during
reasonable business hours at its principal place of business. The
foregoing shall in no way be deemed to limit the ability of each
Purchaser to rely on the representations and warranties set forth
herein or incorporated herein by reference.
5.7
No Endorsement . Each Purchaser further acknowledges that
the offer and sale of the Securities has not been passed upon or
the merits thereof endorsed or approved by any state or federal
authorities.
5.8
Non-Registered Securities . Each Purchaser acknowledges that
the offer and sale of the Securities have not been registered under
the Securities Act or any state securities laws and the Securities
and the underlying shares of Common Stock may be resold only if
registered pursuant to the provisions thereunder or if an exemption
from registration is available. Each Purchaser understands that the
offer and sale of the Securities is intended to be exempt from
registration under the Securities Act, based, in part, upon the
representations, warranties and agreements of such Purchaser
contained in this Agreement.
5.9
No Resale . Each Purchaser represents that the Units being
subscribed for, and the securities underlying the subscription, are
being acquired solely for the account of such Purchaser for such
Purchaser’s investment and not with a view to, or for resale
in connection with, any distribution in any jurisdiction where such
sale or distribution would be precluded. By such representation,
such Purchaser means that no other Person has a beneficial interest
in the Units or the Common Stock underlying such Units, and that no
other Person has furnished or will furnish directly or indirectly,
any part of or guarantee the payment of any part of the
consideration to be paid by such Purchaser to the Company in
connection therewith. Such Purchaser does not intend to dispose of
all or any part of the Units or the Common Stock underlying such
Units except in compliance with the provisions of the Securities
Act and applicable state securities laws, and understands that the
Units and the Common Stock underlying the Units are being offered
pursuant to a specific exemption under the provisions of the
Securities Act, which exemption(s) depends, among other things,
upon the compliance with the provisions of the Securities
Act.
5.10
ERISA-based Investment . If Purchaser is acquiring the Units
through a qualified pension, profit-sharing, stock bonus, Keogh or
401(k) plan or other pension or retirement plan qualified under
Section 401(a) of the Internal Revenue Code of 1986, as amended
(the “Code”), (such plans are referred to collectively
as “Qualified Plans”) then Purchaser represents that
the Qualified Plan (i) provides for a segregated account for the
investor-beneficiary and (ii) gives the investor-beneficiary the
power to direct each plan investment to the extent of the
investor’s voluntary contributions plus the investor’s
share of vested employer contributions. In addition, Purchaser
represents that (a) the Purchaser is aware of certain federal
income tax considerations applicable to Qualified Plans and IRAs,
and (b) the Purchaser has determined that an investment in
Preferred Shares is not a prohibited transaction under the Employee
Retirement Income Security Act of 1974, as amended
(“ERISA”), or the Code and has taken into account the
requirements of prudence, diversification and any other applicable
responsibilities imputed under ERISA or elsewhere.
5.11
Legend . Each Purchaser hereby acknowledges and agrees that
the Company may insert the following or similar legend on the face
of the certificates evidencing the Securities purchased by such
Purchaser and the Warrant Shares issued upon the exercise thereof,
as the case may be, if required in compliance with the Securities
Act or state securities laws:
- 5 -
|
|
|
|
|
“These securities have not
been registered under the Securities Act of 1933, as amended (the
“Securities Act”), or any state securities laws and may
not be sold or otherwise transferred or disposed of except pursuant
to an effective registration statement under the Securities Act and
any applicable state securities laws, or an opinion of counsel
satisfactory to counsel to the issuer that an exemption from
registration under the Securities Act and any applicable state
securities laws is available.”
|
5.12
Broker’s or Finder’s Commissions . No finder,
broker, agent, financial person or other intermediary has acted on
behalf of any Purchaser in connection with the sale of the Units by
the Company or the consummation of this Agreement or any of the
transactions contemplated hereby.
Each
Purchaser certifies that each of the foregoing representations and
warranties by such Purchaser set forth in this Section 5 is true as
of the date hereof and shall survive such date.
6. Representations and
Warranties of the Company .
The
Company represents and warrants to the Purchasers as follows as of
the Closing, each such representation and warranty being made
subject to such disclosures as are made pursuant to this Agreement
or any schedule or exhibit delivered in connection herewith at the
Closing:
6.1
Organization, Good Standing and Qualification . The Company
is a corporation duly organized, validly existing and in good
standing under the laws of the State of Minnesota. The Company has
full corporate power and authority to own and hold its properties
and to conduct its business. The Company is duly licensed or
qualified to do business, and in good standing, in each
jurisdiction in which the nature of its business requires
licensing, qualification or good standing, except for any failure
to be so licensed or qualified or in good standing that would not
have a material adverse effect on the Company or its results of
operations, assets and financial condition, taken as a whole, or on
its ability to perform its obligations under this Agreement or to
issue the Units (a “ Material Adverse Effect
”).
6.2
Capitalization . As of the Initial Closing, the authorized
capital stock of the Company will consist of 20,000,000 shares of
Common Stock, a par value of $0.001 per share. Immediately prior to
the Initial Closing, approximately 1,096,829 shares of Common Stock
will be issued and outstanding. As of the Initial Closing, all the
outstanding shares of Common Stock will have been duly authorized
and validly issued and will be fully paid and nonassessable and
free of preemptive rights created by or through the Company, and
will have been issued in compliance with all federal and state
securities laws, and will not have been issued in violation of any
preemptive rights or similar rights to subscribe for or purchase
securities. Other than as described in the Company’s Offering
Memorandum dated on or about January 31, 2008 (the
“Memorandum”), there are no options, warrants or other
rights, convertible debt, agreements, arrangements or commitments
of any character obligating the Company to issue or sell any shares
of capital stock of or other equity interests in the Company. The
Company is not obligated to retire, redeem, repurchase or otherwise
reacquire any of its capital stock or other securities. There are
no stockholders agreements, voting agreements or other similar
agreements with respect to the Common Stock to which the Company is
a party. Except as disclosed in or pursuant to this Agreement, the
Company does not directly or indirectly own or have any investment
in any of the capital stock of, or any other proprietary interest
in, any Person. The Company has not adopted a stockholders rights
plan, poison pill or similar arrangement.
6.3
Corporate Power, Authorization; Enforceability . The Company
has full corporate power and authority to execute, deliver and
enter into this Agreement, the Charter Amendment, the Escrow
Agreement and the Registration Rights Agreement (collectively, the
“ Transaction Documents ”) and to
- 6 -
consummate the transactions
contemplated hereby and thereby. Except as contemplated by this
Agreement, including the next two succeeding sentences, all action
on the part of the Company, its directors or stockholders necessary
for the authorization, execution, delivery and performance of the
Transaction Documents by the Company, the authorization, sale,
issuance and delivery of the Units contemplated hereby and the
performance of the Company’s obligations hereunder and
thereunder has been taken. The Units to be purchased on the Closing
Date and the shares of Common Stock issuable upon the exercise of
the Warrants have been duly authorized and, when issued in
accordance with this Agreement, will be validly issued, fully paid
and nonassessable and will be free and clear of any mortgage, deed
of trust, pledge, hypothecation, assignment, encumbrance, lien
(statutory or other) or preference, priority, right or other
security interest or preferential arrangement of any kind or nature
whatsoever (collectively, “ Liens ”) imposed by
or through the Company other than restrictions imposed by this
Agreement and the Registration Rights Agreeme